glp-1 medications tirzepatide List of approved and pending Tirzepatide is an advanced GLP-1

The Australian Therapeutic Goods Administration (TGA) has issued safety alerts after laboratory testing confirmed that some imported weight loss products marketed as GLP-1 therapies are counterfeit and contain no GLP-1 receptor agonist at all

It provides blood sugar control and also significantly impacts body weight through delayed gastric emptying and enhanced satiety signaling in the brain

Furthermore, there are also several reports describing episodes of pulmonary aspiration in appropriately fasted patients on GLP-1RA therapy [7, 1518]

Exendin-4 Attenuates Remodeling in the Remote Myocardium of Rats After an Acute Myocardial Infarction by Activating -Arrestin-2, Protein Phosphatase 2A, and Glycogen Synthase Kinase-3 and Inhibiting -Catenin

Additionally, individuals with certain heart conditions or those who have recently had surgery may face a deferral period

Noticeably, both medications have been reported for gastrointestinal side effects and increasing the chances of pancreatitis [10]